The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer

被引：0
|
作者：
Lei Tian
Yanfei Peng
Kuo Yang
Jiasong Cao
Xiaoling Du
Zhixian Liang
Jiandang Shi
Ju Zhang
机构：
[1] Nankai University,Department of Biochemistry and Molecular Biology, College of Life Sciences, Bioactive Materials Key Lab of the Ministry of Education
[2] Tianjin University of Traditional Chinese Medicine,School of Integrative Medicine
[3] The Second Hospital of Tianjin Medical University,Department of Urology
[4] The Chinese University of Hong Kong,School of Biomedical Sciences
来源：
Cell Communication and Signaling | / 20卷
关键词：
Bicalutamide; ERα; NRF2; Castration-resistant; PCa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer
    Tian, Lei
    Peng, Yanfei
    Yang, Kuo
    Cao, Jiasong
    Du, Xiaoling
    Liang, Zhixian
    Shi, Jiandang
    Zhang, Ju
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [2] Understanding the Role of NRF2 Signalling in Cancer
    Singh, Pooja G.
    Gopenath, T. S.
    Basalingappa, Kanthesh M.
    Bharadwaj, M. N. Ramesh
    Ilangovan, R.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2022, 23 (10) : 672 - 683
  • [3] p62 promotes proliferation, apoptosis-resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis
    Jiang, Ganggang
    Liang, Xue
    Huang, Yiqiao
    Lan, Ziquan
    Zhang, Zhiming
    Su, Zhengming
    Fang, Zhiyuan
    Lai, Yuxiong
    Yao, Wenxia
    Liu, Ting
    Hu, La
    Wang, Fen
    Huang, Hai
    Liu, Leyuan
    Jiang, Xianhan
    ONCOLOGY REPORTS, 2020, 43 (05) : 1547 - 1557
  • [4] O-GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2
    Zhang, Yihan
    Sun, Changning
    Ma, Leina
    Xiao, Guokai
    Gu, Yuchao
    Yu, Wengong
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (10):
  • [5] Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH
    Fernandez-Gines, Raquel
    Encinar, Jose Antonio
    Escoll, Maribel
    Carnicero-Senabre, Daniel
    Jimenez-Villegas, Jose
    Garcia-Yaguee, Angel J.
    Gonzalez-Rodriguez, Agueda
    Garcia-Martinez, Irma
    Valverde, Angela M.
    Rojo, Ana I.
    Cuadrado, Antonio
    REDOX BIOLOGY, 2024, 69
  • [6] ROS-independent Nrf2 activation in prostate cancer
    Bellezza, Ilaria
    Scarpelli, Paolo
    Pizzo, Salvatore V.
    Grottelli, Silvia
    Costanzi, Egidia
    Minelli, Alba
    ONCOTARGET, 2017, 8 (40) : 67506 - 67518
  • [7] Activation of Nrf2 in fibroblasts promotes a skin aging phenotype via an Nrf2-miRNA-collagen axis
    Hiebert, Paul
    Martyts, Anastasiya
    Schwestermann, Jonas
    Janke, Katharina
    Hafner, Juerg
    Boukamp, Petra
    Mazza, Edoardo
    Werner, Sabine
    MATRIX BIOLOGY, 2022, 113 : 39 - 60
  • [8] Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients
    Sekino, Yohei
    Oue, Naohide
    Mukai, Shoichiro
    Shigematsu, Yoshinori
    Goto, Keisuke
    Sakamoto, Naoya
    Sentani, Kazuhiro
    Hayashi, Tetsutaro
    Teishima, Jun
    Matsubara, Akio
    Yasui, Wataru
    PROSTATE, 2019, 79 (02): : 234 - 242
  • [9] USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2
    Cui, Jing
    Guo, Yao
    Yin, Tao
    Gou, Shanmiao
    Xiong, Jiongxin
    Liang, Xueyi
    Lu, Chong
    Peng, Tao
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [10] Targeting Nrf2-antioxidant signalling reverses acquired cabazitaxel resistance in prostate cancer cells
    Endo, Satoshi
    Kawai, Mina
    Hoshi, Manami
    Segawa, Jin
    Fujita, Mei
    Matsukawa, Takuo
    Fujimoto, Naohiro
    Matsunaga, Toshiyuki
    Ikari, Akira
    JOURNAL OF BIOCHEMISTRY, 2021, 170 (01): : 89 - 96
12345